08.04.2013 Views

Lung Cancer.pdf

Lung Cancer.pdf

Lung Cancer.pdf

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Surgical Treatment of Locally Advanced Non–Small Cell <strong>Lung</strong> <strong>Cancer</strong> 135<br />

diation therapy because it is associated with an increased risk of wound<br />

healing problems (especially at bronchial margins) after surgery and because<br />

the dose that can be delivered before surgery is lower than the dose<br />

that can be delivered after (45 Gy vs 66 Gy). If the final pathologic margins<br />

after surgery are involved, postoperative radiation therapy is delivered to<br />

reduce the risk of local-regional recurrence.<br />

Patients with T4N0–1 Pancoast tumors are treated in a phase II study<br />

evaluating surgical resection followed by postoperative chemoradiation.<br />

After surgery, radiation therapy is delivered over 5 to 6 weeks. Patients<br />

receive 2 fractions per day, to a total dose of 60 Gy in patients with negative<br />

margins or 64.8 Gy in patients with positive margins, plus concurrent<br />

chemotherapy (cisplatin 50 mg/m 2 on days 1 and 8 and etoposide<br />

given by mouth 30 to 60 minutes prior to each administration of radiation<br />

therapy on days 1 through 5 and 8 through 12, with this chemotherapy<br />

cycle repeated starting on day 29). Prophylactic cranial irradiation<br />

(25 Gy in 10 fractions of 2.5 Gy) is given on completion of chest irradiation<br />

because of the high risk of brain recurrences. Three additional cycles<br />

of chemotherapy are delivered after prophylactic cranial irradiation.<br />

This aggressive approach has resulted in long-term survival in a fraction<br />

of patients in whom negative pathologic margins can be obtained<br />

(Gandhi et al, 1999). Because of the complexity of this operation, careful<br />

coordination between the medical oncologists, surgical oncologists, and<br />

radiation oncologists is required. These rare tumors should be treated at<br />

an experienced referral center to ensure the maximum chance for overall<br />

success.<br />

Operative Strategy<br />

Surgery for T4N0–1 non-Pancoast tumors is usually performed after induction<br />

chemotherapy. In some cases, the preoperative chemotherapy has<br />

significantly downstaged the tumor (Figure 7–2). Nevertheless, the original<br />

extent of the tumor must be kept in mind to avoid leaving behind tissue<br />

that may still contain microscopic deposits of viable tumor. To help ensure<br />

complete resection, scans showing the original extent of the tumor<br />

are displayed in the operating room during surgery. The main T4 tumors<br />

approached surgically are tumors that invade the carina, vertebral body,<br />

or atrium. Resection of the vertebral body will be discussed in the discussion<br />

of Pancoast tumors.<br />

Invasion of the carina is rare and should be approached surgically only<br />

if all the mediastinal nodes are negative on cervical mediastinoscopy. All<br />

carinal resections should focus on minimizing the tension on airway anastomoses<br />

by developing a pretracheal plane without interrupting the lateral<br />

blood supply of the trachea. The hilum can also be mobilized with an<br />

inferior hilar release of the pericardium on either side, and a suprahyoid<br />

laryngeal release can be performed if necessary. After surgery, all patients<br />

are put in cervical flexion, with a stitch secured from the chin to the ante-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!